Kothapalli Srikanth R, Kesireddy Meghana
Internal Medicine, CHI Health St. Francis, Grand Island, USA.
Hematology-Oncology, The University of Nebraska Medical Center, Omaha, USA.
Cureus. 2024 Aug 1;16(8):e65945. doi: 10.7759/cureus.65945. eCollection 2024 Aug.
Trimethoprim-sulfamethoxazole (TMP-SMX), a widely used antibiotic, is associated with both predictable dose-dependent side effects and rare, idiosyncratic adverse reactions. Here, we report the case of a previously healthy, non-G6PD-deficient, 27-year-old male who developed three idiosyncratic reactions: severe thrombocytopenia, aseptic meningitis, and hepatitis concurrently following TMP-SMX administration. The Naranjo adverse reaction probability score was 7, implying TMP-SMX as the probable cause of the clinical presentation. After a comprehensive workup to rule out alternate etiologies, we have established TMP-SMX as the culprit. Our case highlights the importance of early recognition of TMP-SMX-induced rare adverse events for appropriate management to mitigate long-term sequelae and ensure favorable patient outcomes.
甲氧苄啶-磺胺甲恶唑(TMP-SMX)是一种广泛使用的抗生素,它既会引发可预测的剂量依赖性副作用,也会导致罕见的特异质性不良反应。在此,我们报告一例病例,一名27岁、既往健康且非葡萄糖-6-磷酸脱氢酶(G6PD)缺乏的男性,在服用TMP-SMX后同时出现了三种特异质性反应:严重血小板减少、无菌性脑膜炎和肝炎。纳伦霍不良反应概率评分是7分,这意味着TMP-SMX可能是临床表现的病因。在进行全面检查以排除其他病因后,我们确定TMP-SMX为罪魁祸首。我们的病例强调了早期识别TMP-SMX引起的罕见不良事件对于适当管理以减轻长期后遗症并确保患者获得良好预后的重要性。